Biotechnology and Pharmaceuticals

Austerity in Europe Puts Pressure on Drug Companies

Profits at pharmaceutical companies have been declining or showing little growth for the last year as austerity measures across Europe lead to cuts in health care spending. Some analysts say this trend could continue until at least 2014. Budget cuts mean that many European governments are not willing to pay as much for pills. But … Continue reading →